It’s time for business to fight Malaria.
An investment case.
BAAM has produced a comprehensive resource that describes the challenge of flat-lining funding for malaria programming while arming health leaders with the evidence necessary for increasing private sector engagement in the fight against malaria.
This paper helps understand the value of investing in malaria efforts and helps individuals within these organizations better make the internal case for increasing support for initiatives.
It’s time to boost efforts to move corporate conversations from whether to engage in the fight against malaria, to how to best engage.
Malaria elimination is possible and critical to fighting other current and future diseases that may emerge. Investments in ending malaria also can be used to fight the current and future diseases. Despite the added challenges of COVID-19, malaria elimination remains a viable goal for all countries.
Two decades of investments in malaria have saved 7.6 million lives and prevented 1.5 billion malaria cases. This significantly reduced burdens on health systems worldwide and improved maternal and child health, survival, and prosperity.
Photo Credit: Novartis
Photo Credit: The Borgen Project
Since 2000, strong political commitment and effective interventions have drastically reduced the global burden of malaria. In that time, over 20 countries from every region worldwide reached the target of zero malaria cases, proving that elimination is possible.
The ongoing spread of COVID-19 continues to threaten the malaria response, particularly in the highest malaria burden countries where the rate of progress has slowed in recent years. As long as malaria exists, it will be a chronic engine of poverty and inequality, burdening the poorest and most vulnerable communities, and potentially resurging in times of crisis.
